ClinicaliQ Trial Snapshot
- Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System — Recruiting • Cardiology / Cardiovascular • NCT04798261.
- What is being tested: Long-term safety, performance, and functional outcomes of the Indigo Aspiration System, a mechanical thrombectomy device designed to remove blood clots in patients with pulmonary embolism.
- Patient eligibility overview: The study enrolls patients with pulmonary embolism who are candidates for treatment with the Indigo Aspiration System, assessed according to standard clinical criteria for mechanical thrombectomy.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
Eligibility Snapshot
- : 1. Clinical signs and symptoms consistent with acute PE with duration of 14 days or less 2. RV/LV ratio ≥ 0.9 assessed by diagnostic computed tomographic angiography (CTA) or echocardiogram 3. Frontline endovascular treatment with the Indigo Aspiration System per IFU
- Patient is ≥ 18 years of age 5. Informed consent obtained per Institutional Review Board/Ethics Committee requirements
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.